MEP1508A - Postupak pripremanja racemskog citaloprama i/ili s-ili r-citaloprama separacijom smješe r- i s- citaloprama - Google Patents

Postupak pripremanja racemskog citaloprama i/ili s-ili r-citaloprama separacijom smješe r- i s- citaloprama

Info

Publication number
MEP1508A
MEP1508A MEP-15/08A MEP1508A MEP1508A ME P1508 A MEP1508 A ME P1508A ME P1508 A MEP1508 A ME P1508A ME P1508 A MEP1508 A ME P1508A
Authority
ME
Montenegro
Prior art keywords
citalopram
acid addition
addition salt
racemic
precipitate
Prior art date
Application number
MEP-15/08A
Other languages
English (en)
Inventor
Rikke Eva Humble
Troels Volsgaard Christensen
Michael Harold Rock
Ole Nielsen
Hans Petersen
Robert J M Dancer
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MEP1508A publication Critical patent/MEP1508A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Pronalazak se odnosi na postupak za pripremanje recemske citalopram slobodne baze ili od toga nastale kisjele adicione soli i/ili R- i S-citaloprama kao slobodne baze ili od toga nastale kisjele adicone soli separacijom smješe R- i S –citaloprama sa više od 50% jednog od enantiomera u frakciju koja sadrži racemski citalopram i/ili frakciju S-citaloprama ili R- citaloprama naznačen time što i) se citalopram istaloži iz rastvarača kao slobodna baza ili od toga kisjela adiciona so; ii) se formirani talog odvaja iz matične tečnosti iia) ako je talog kristalan opciono se rekristališe jednom ili više puta da se formira racemski citalopram, i onda se opciono pretvara u od toga nastalu kisjelu adicionu so; iib) ako talog nije kristalan, koraci i) i ii) se opciono ponavljaju sve dok se ne dobije kristalni talog i kristalni talog se opciono jednom ili više puta rekristališe da formira racemski citalopram, i onda se opciono pretvara u od toga nastalu kisjelu adicionu so; iii) se matična tečnost opciono podvrgava daljem prečišćavanju i S- citalopram ili R- citalopram izoluje iz matične tečnosti i opciono pretvaraju u od toga nastalu kisjelu adicionu so.
MEP-15/08A 2001-06-25 2002-06-25 Postupak pripremanja racemskog citaloprama i/ili s-ili r-citaloprama separacijom smješe r- i s- citaloprama MEP1508A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100991 2001-06-25
PCT/DK2002/000426 WO2003000672A1 (en) 2001-06-25 2002-06-25 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram

Publications (1)

Publication Number Publication Date
MEP1508A true MEP1508A (xx) 2010-02-10

Family

ID=8160584

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-2008-15A ME00027B (me) 2001-06-25 2002-06-25 Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smješe r- i s-citaloprama
MEP-15/08A MEP1508A (xx) 2001-06-25 2002-06-25 Postupak pripremanja racemskog citaloprama i/ili s-ili r-citaloprama separacijom smješe r- i s- citaloprama

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MEP-2008-15A ME00027B (me) 2001-06-25 2002-06-25 Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smješe r- i s-citaloprama

Country Status (40)

Country Link
US (1) US7112686B2 (bs)
EP (1) EP1412341B1 (bs)
JP (2) JP4377219B2 (bs)
KR (4) KR100939945B1 (bs)
CN (2) CN101440079B (bs)
AR (2) AR034612A1 (bs)
AT (1) ATE284395T1 (bs)
BG (1) BG66372B1 (bs)
BR (1) BRPI0210574B8 (bs)
CA (2) CA2691149C (bs)
CO (1) CO5550420A2 (bs)
CZ (1) CZ305034B6 (bs)
DE (1) DE60202216T2 (bs)
DK (1) DK1412341T3 (bs)
EA (1) EA006446B1 (bs)
ES (1) ES2233834T3 (bs)
HK (2) HK1068627A1 (bs)
HR (1) HRP20031075B1 (bs)
HU (1) HU228476B1 (bs)
IL (1) IL159229A0 (bs)
IS (1) IS2426B (bs)
JO (1) JO2389B1 (bs)
MA (1) MA26260A1 (bs)
ME (2) ME00027B (bs)
MX (1) MXPA03011770A (bs)
MY (1) MY133471A (bs)
NO (2) NO329873B1 (bs)
NZ (1) NZ530104A (bs)
PE (1) PE20030122A1 (bs)
PL (1) PL366560A1 (bs)
PT (1) PT1412341E (bs)
RS (1) RS50673B (bs)
SI (1) SI1412341T1 (bs)
SK (1) SK287696B6 (bs)
TN (1) TNSN02062A1 (bs)
TW (1) TWI236473B (bs)
UA (1) UA75147C2 (bs)
UY (2) UY27356A1 (bs)
WO (1) WO2003000672A1 (bs)
ZA (1) ZA200309633B (bs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040970A1 (es) 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
PT1581483E (pt) * 2002-12-23 2012-07-24 Lundbeck & Co As H Processo para a preparação de diol de citalopram racécmico e/ou dos dióis de s- ou r-citalopram e a utilização desses dióis para a preparação de citalopram racémico, rcitalopram e/ou s-citalopram
WO2004056791A1 (en) 2002-12-23 2004-07-08 H. Lundbeck A/S Escitalopram hydrobromide and a method for the preparation thereof
EP1581483B1 (en) * 2002-12-23 2012-06-06 H. Lundbeck A/S A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR i S- /i OR i R- /i CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, i R- /i CITALOPRAM AND/OR i S- /i CITALOPRAM
WO2004085416A1 (en) * 2003-03-24 2004-10-07 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
CN100569765C (zh) * 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050196453A1 (en) 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
BRPI0508266A (pt) * 2004-03-05 2007-07-31 Lundbeck & Co As H partìculas cristalinas de oxalato de escitalopram, forma de dosagem única sólida, e, métodos para a fabricação de partìculas cristalinas de oxalato de escitalopram e para reduzir a quantidade de hidroxila que contém impurezas no citalopram, escitalopram ou uma mistura não racêmica de r- e s-citalopram
ITMI20040717A1 (it) 2004-04-09 2004-07-09 Adorkem Technology Spa Procedimento chemo-enzimatico per la preparazione dell'escitalopram
JP2006008603A (ja) * 2004-06-25 2006-01-12 Sumitomo Chemical Co Ltd 光学活性シタロプラムの製造方法、その中間体およびその製造方法
EP2141156A1 (en) * 2004-08-23 2010-01-06 Sun Pharma Global FZE Process for Preparation of Citalopram and Enantiomers
US7989645B2 (en) * 2004-08-23 2011-08-02 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
EP1901714A2 (en) * 2005-05-20 2008-03-26 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
EP1954257A4 (en) 2005-10-14 2009-05-20 Lundbeck & Co As H METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FI121570B (fi) 2007-09-11 2011-01-14 Lundbeck & Co As H Menetelmä essitalopraamin valmistamiseksi
US8022232B2 (en) * 2007-09-11 2011-09-20 H. Lundbeck A/S Method for manufacture of escitalopram
CN100548974C (zh) * 2007-10-11 2009-10-14 浙江大学 西酞普兰中间体的萃取分离方法
CN101560199B (zh) * 2008-04-16 2013-09-18 北京德众万全药物技术开发有限公司 一种依地普仑的制备方法
TWI381813B (zh) 2010-01-12 2013-01-11 Taiwan Paiho Ltd A Velcro assembly for a foamed article and a foamed article comprising the adhesive tape assembly

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DE69935355T2 (de) * 1999-10-25 2007-11-08 H. Lundbeck A/S, Valby Verfahren zur Herstellung von Citalopram

Also Published As

Publication number Publication date
CA2450890A1 (en) 2003-01-03
CA2450890C (en) 2011-02-15
AU2002344948B2 (en) 2007-08-16
CZ2004131A3 (cs) 2004-04-14
CO5550420A2 (es) 2005-08-31
EA200400082A1 (ru) 2004-06-24
TNSN02062A1 (en) 2005-12-23
RS101403A (en) 2007-02-05
MXPA03011770A (es) 2004-04-02
NZ530104A (en) 2006-08-31
CA2691149C (en) 2011-09-13
BR0210574B1 (pt) 2014-03-04
NO329873B1 (no) 2011-01-17
UY35850A (es) 2016-06-30
JP5064436B2 (ja) 2012-10-31
US20040259940A1 (en) 2004-12-23
PE20030122A1 (es) 2003-02-12
AR083483A2 (es) 2013-02-27
BR0210574A (pt) 2004-08-03
ME00027B (me) 2010-02-10
HUP0400293A3 (en) 2007-05-29
KR20090031958A (ko) 2009-03-30
KR20040030702A (ko) 2004-04-09
CN101440079B (zh) 2011-05-25
JP2004536093A (ja) 2004-12-02
CA2691149A1 (en) 2003-01-03
CN100429208C (zh) 2008-10-29
HRP20031075B1 (en) 2011-12-31
NO20035671L (no) 2003-12-18
WO2003000672A1 (en) 2003-01-03
BG66372B1 (bg) 2013-10-31
NO335106B1 (no) 2014-09-15
CN1520405A (zh) 2004-08-11
PL366560A1 (en) 2005-02-07
IS7068A (is) 2003-12-08
BG108532A (bg) 2005-04-30
HK1068627A1 (en) 2005-04-29
HRP20031075A2 (en) 2004-04-30
CZ305034B6 (cs) 2015-04-08
EP1412341A1 (en) 2004-04-28
KR20080100498A (ko) 2008-11-18
TWI236473B (en) 2005-07-21
JP4377219B2 (ja) 2009-12-02
MA26260A1 (fr) 2004-09-01
HUP0400293A2 (hu) 2004-09-28
EP1412341B1 (en) 2004-12-08
IL159229A0 (en) 2004-06-01
KR100939945B1 (ko) 2010-02-04
MY133471A (en) 2007-11-30
SK512004A3 (en) 2004-05-04
ZA200309633B (en) 2005-02-23
HU228476B1 (en) 2013-03-28
HK1132729A1 (en) 2010-03-05
EA006446B1 (ru) 2005-12-29
DE60202216D1 (de) 2005-01-13
UA75147C2 (en) 2006-03-15
IS2426B (is) 2008-10-15
NO20035671D0 (no) 2003-12-18
ATE284395T1 (de) 2004-12-15
RS50673B (sr) 2010-06-30
BRPI0210574B8 (pt) 2021-05-25
DK1412341T3 (da) 2005-04-04
KR100902530B1 (ko) 2009-06-15
JO2389B1 (en) 2007-06-17
CN101440079A (zh) 2009-05-27
NO20101420L (no) 2003-12-18
JP2009203233A (ja) 2009-09-10
ES2233834T3 (es) 2005-06-16
KR20100052550A (ko) 2010-05-19
US7112686B2 (en) 2006-09-26
SI1412341T1 (en) 2005-04-30
DE60202216T2 (de) 2005-12-08
UY27356A1 (es) 2003-01-31
PT1412341E (pt) 2005-04-29
AR034612A1 (es) 2004-03-03
SK287696B6 (sk) 2011-06-06

Similar Documents

Publication Publication Date Title
TNSN02062A1 (en) Process for the preparation of racemic citalopram and/or s- or r -citalopram by separation of a mixture of r- and s-citalopram
IS7886A (is) Aðferð við framleiðslu á rasemísku sítalópram díóli og/eða S- eða R- sítalópram díólum og notkun slíkra díóla við framleiðslu á rasemísku sítalóprami, R-sítalóprami og/eða S-sítalóprami
JP2004536093A5 (ja) R−及びs−シタロプラムの混合物を分離することによってラセミシタロプラム及びs−もしくはr−シタロプラムを製造する方法
DE60332776D1 (de) Herstellung von Delta-9-Tetrahydrocannabinol
SE0200730D0 (sv) Kristallin bas av citalopram
CA2325919A1 (en) Processes for the preparation of threo-1,2-epoxy-3-amino-4-phenylbutane derivatives
NO20015874D0 (no) Modifisert prosess for produksjon av alginat med höyt mannuronsyre-innhold
ATE316082T1 (de) Prozess zur herstellung von r(+)alpha-liponsäure
WO2003048131A1 (fr) Intermediaire destine a la biotine et procede de production associe
TW200512202A (en) A process for the preparation of racemic citalopram diol and/or S- or R-citalopram diols and the use of such diols for the preparation of racemic citalopram, R-citalopram and/or S-citalopram
AU2003295152A1 (en) Solid-phase preparation of (18f)fluorohaloalkanes
JP2009062392A (ja) 環化法
WO2003087118A3 (de) Verfahren zur herstellung von beta-l-2'deoxy-thymidin
CA2361565A1 (en) Synthesis of ethyleneimine dimer
HU0201584D0 (bs)
JPS5242835A (en) Process for preparation of 6-methyl-2,3,4-trimethoxyphenol
ATE295350T1 (de) Verfahren zur herstellung von 3 spiro'cyclohexan- 1,3'-'3höindolin-2'-onöderivaten